X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (767) 767
Publication (76) 76
Book Review (11) 11
Book Chapter (9) 9
Book / eBook (5) 5
Dissertation (3) 3
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (608) 608
index medicus (490) 490
female (312) 312
male (305) 305
transplantation (254) 254
middle aged (226) 226
polyomavirus infections - virology (210) 210
immunology (203) 203
adult (197) 197
bk virus (197) 197
polyomavirus (183) 183
health aspects (174) 174
kidney transplantation (160) 160
infection (157) 157
viruses (156) 156
animals (152) 152
infectious diseases (147) 147
kidney transplantation - adverse effects (128) 128
tumor virus infections - virology (128) 128
aged (125) 125
polyomavirus infections - epidemiology (122) 122
risk factors (121) 121
virus diseases (117) 117
surgery (111) 111
bk virus - isolation & purification (108) 108
kidneys (104) 104
virology (104) 104
polyomavirus infections - diagnosis (103) 103
oncology (102) 102
nephropathy (99) 99
immunosuppression (97) 97
polyomavirus infections - complications (93) 93
polyomavirus infections - immunology (92) 92
research (92) 92
replication (91) 91
infections (86) 86
polyomavirus infections - prevention & control (85) 85
viral load (85) 85
cancer (81) 81
jc virus (81) 81
mice (81) 81
polyoma virus (79) 79
dna (77) 77
immunosuppressive agents - adverse effects (77) 77
polymerase chain reaction (76) 76
analysis (75) 75
immunotherapy (74) 74
medicine (73) 73
adolescent (72) 72
polyomavirus - genetics (72) 72
antiviral agents - therapeutic use (71) 71
graft rejection - prevention & control (71) 71
recipients (71) 71
immunosuppressive agents - therapeutic use (70) 70
kidney diseases (70) 70
polyomavirus-associated nephropathy (70) 70
progressive multifocal leukoencephalopathy (70) 70
retrospective studies (70) 70
child (69) 69
disease (67) 67
organ transplant recipients (67) 67
tumor virus infections - epidemiology (67) 67
diagnosis (66) 66
risk-factors (66) 66
tumor virus infections - immunology (66) 66
polyomavirus infections - drug therapy (65) 65
prevalence (65) 65
immunocompromised host (63) 63
polyomavirus - isolation & purification (63) 63
tumor virus infections - diagnosis (63) 63
kidney diseases - virology (61) 61
treatment outcome (61) 61
viremia (60) 60
transplants & implants (59) 59
virus (59) 59
renal-transplantation (58) 58
children (57) 57
merkel cell polyomavirus (56) 56
tumor virus infections - prevention & control (56) 56
biopsy (54) 54
bk virus - genetics (53) 53
tumor virus infections - complications (53) 53
young adult (53) 53
time factors (52) 52
urology & nephrology (52) 52
hemorrhagic cystitis (49) 49
infectious and parasitic diseases (48) 48
polyomavirus infections - pathology (48) 48
bk virus - immunology (47) 47
carcinoma (47) 47
child, preschool (47) 47
epidemiology (47) 47
incidence (47) 47
polyomavirus infections - etiology (47) 47
microbiology (46) 46
polyomavirus - immunology (46) 46
cytomegalovirus (45) 45
article (44) 44
viral infections (44) 44
care and treatment (43) 43
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (766) 766
Chinese (4) 4
Italian (4) 4
French (3) 3
German (3) 3
Japanese (3) 3
Spanish (3) 3
Czech (1) 1
Polish (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Transplantation, ISSN 0041-1337, 2016, Volume 100, Issue 3, pp. 655 - 661
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2010, Volume 16, Issue 10, pp. 1428 - 1435
Major advances in the monitoring and treatment of viral infections after hematopoietic stem cell transplantation (HSCT) have been achieved over the last... 
Hematology, Oncology and Palliative Medicine | Cytomegalovirus | DNAemia | Epstein-Barr virus | Antithymocyte globulin | Human Herpesvirus 6 | Viral load | RISK-FACTORS | BARR-VIRUS DNA | BONE-MARROW-TRANSPLANTATION | PERIPHERAL-BLOOD | CYTOMEGALOVIRUS-INFECTION | IMMUNOLOGY | TRANSPLANTATION | POLYMERASE-CHAIN-REACTION | REACTIVATION | PEDIATRIC-PATIENTS | DISEASE | LYMPHOPROLIFERATIVE DISORDERS | HEMATOLOGY | Adenoviridae Infections - drug therapy | Virus Diseases - epidemiology | Graft vs Host Disease - complications | Prospective Studies | Humans | Postoperative Complications - prevention & control | Child, Preschool | Infant | Male | Transplantation, Homologous | Adenoviridae Infections - prevention & control | Bone Marrow Transplantation - statistics & numerical data | Herpesviridae Infections - prevention & control | Young Adult | Adenoviridae Infections - epidemiology | Virus Diseases - drug therapy | Ganciclovir - therapeutic use | Female | Postoperative Complications - drug therapy | Child | Viremia - diagnosis | Antiviral Agents - therapeutic use | Hematopoietic Stem Cell Transplantation - statistics & numerical data | Polyomavirus Infections - prevention & control | Polyomavirus Infections - epidemiology | Postoperative Complications - epidemiology | Herpesviridae Infections - diagnosis | Antiviral Agents - administration & dosage | Adenoviridae Infections - diagnosis | Herpesviridae Infections - drug therapy | Postoperative Complications - diagnosis | BK Virus - isolation & purification | Peripheral Blood Stem Cell Transplantation - statistics & numerical data | DNA, Viral - blood | Hematologic Neoplasms - surgery | Polyomavirus Infections - diagnosis | Virus Diseases - diagnosis | Adolescent | Viremia - epidemiology | Antilymphocyte Serum | Polyomavirus Infections - drug therapy | Virus Diseases - prevention & control | Herpesviridae Infections - epidemiology | Premedication | Virus diseases | Ganciclovir | DNA | Stem cells | Transplantation | Children | Acyclovir | Health aspects | Hematopoietic stem cells
Journal Article
Kidney International, ISSN 0085-2538, 09/2012, Volume 82, Issue 6, pp. 664 - 675
Viral infection in the kidney is characterized by tubular injury induced directly by the virus and/or by cytotoxic lymphocytes. Previously, we found that human... 
apoptosis | BK virus | cytomegalovirus | tubular epithelial cells | dsRNA receptors | I INTERFERON INDUCTION | EPSTEIN-BARR | HUMAN CYTOMEGALOVIRUS | RIG-I | GENE-I | DEPENDENT APOPTOSIS | TOLL-LIKE RECEPTOR-3 | ENDOTHELIAL-CELLS | UROLOGY & NEPHROLOGY | MELANOMA-CELLS | POLYOMAVIRUS NEPHROPATHY | Inflammation - pathology | Herpesvirus 4, Human - genetics | Humans | Middle Aged | Tumor Necrosis Factor-alpha - genetics | Male | Virus Diseases - virology | Cytomegalovirus Infections - immunology | Cytomegalovirus Infections - genetics | fas Receptor - metabolism | Interferon-Induced Helicase, IFIH1 | Inflammation - metabolism | Cytomegalovirus Infections - virology | Interferon-beta - genetics | Cytomegalovirus Infections - pathology | RNA, Double-Stranded - metabolism | Kidney Tubules - pathology | Kidney Tubules - metabolism | Virus Diseases - genetics | Cytomegalovirus - genetics | DEAD Box Protein 58 | Virus Diseases - immunology | Signal Transduction | Inflammation - virology | BK Virus - genetics | Epithelial Cells - pathology | Toll-Like Receptor 3 - metabolism | Polyomavirus Infections - pathology | Epstein-Barr Virus Infections - pathology | Interferon-beta - metabolism | Polyomavirus Infections - virology | Epithelial Cells - virology | Virus Diseases - pathology | Virus Diseases - prevention & control | Polyomavirus Infections - immunology | Tumor Necrosis Factor-alpha - metabolism | Epithelial Cells - metabolism | Kidney Tubules - virology | Cytomegalovirus Infections - metabolism | Epstein-Barr Virus Infections - prevention & control | Cytomegalovirus Infections - prevention & control | Inflammation Mediators - metabolism | Adult | Female | RNA, Viral - metabolism | Toll-Like Receptor 3 - genetics | DEAD-box RNA Helicases - metabolism | Epstein-Barr Virus Infections - virology | Epstein-Barr Virus Infections - immunology | Polyomavirus Infections - prevention & control | Cells, Cultured | Gene Expression Regulation | Virus Diseases - metabolism | Inflammation - immunology | DEAD-box RNA Helicases - genetics | Biopsy | Aged | Apoptosis | Kidney Transplantation - adverse effects | Fas antigen | CD95 antigen | Epithelial cells | Double-stranded RNA | Melanoma | Antibodies | Cytotoxicity | Inflammation | TLR3 protein | Infection | beta -Interferon | Lymphocytes | Antiviral activity | Toll-like receptors | Injuries | Tumor necrosis factor- alpha | Kidney transplantation
Journal Article
Journal of Immunology Research, ISSN 2314-8861, 2017, Volume 2017, pp. 5672523 - 24
Viral infections represent significant morbidity and mortality factors in kidney transplant recipients, with CMV, EBV, and BKV infections being most common.... 
SOLID-ORGAN TRANSPLANTATION | NATURAL-KILLER-CELLS | REMITTING MULTIPLE-SCLEROSIS | RENAL-ALLOGRAFT RECIPIENTS | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | HUMAN CYTOMEGALOVIRUS-INFECTION | CD8(+) T-LYMPHOCYTES | IMMUNOLOGY | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE | EPSTEIN-BARR-VIRUS | BLOOD MONONUCLEAR-CELLS | Polyomavirus Infections - immunology | Humans | Middle Aged | Kidney - immunology | Male | Cytomegalovirus Infections - immunology | Lymphocyte Depletion | Transplant Recipients | Epstein-Barr Virus Infections - prevention & control | Transplantation, Homologous | BK Virus | Rituximab - therapeutic use | Cytomegalovirus Infections - prevention & control | Cytomegalovirus Infections - virology | Adult | Female | Antibodies, Monoclonal, Humanized - therapeutic use | Epstein-Barr Virus Infections - virology | Antiviral Agents - therapeutic use | Epstein-Barr Virus Infections - immunology | HLA Antigens - immunology | Kidney Transplantation | Alemtuzumab | Viremia - drug therapy | Epstein-Barr Virus Infections - drug therapy | Immunoglobulins, Intravenous - therapeutic use | Cytomegalovirus Infections - drug therapy | Polyomavirus Infections - virology | Viremia - prevention & control | Viremia - immunology | Aged | Desensitization, Immunologic | Polyomavirus Infections - drug therapy | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Cytomegalovirus | Transplants & implants | Lymphocytes | Infections | Genetic testing | Patients | Viral infections | Deoxyribonucleic acid--DNA
Journal Article
Nephrology, ISSN 1320-5358, 07/2018, Volume 23, Issue S2, pp. 31 - 37
ABSTRACT Modern immunosuppressive therapy has dramatically reduced the incidence of acute rejection and improved graft survival in kidney transplant patients.... 
immunosuppression | polyomavirus BK | tubulointerstitial nephritis | allograft biopsy | adenovirus | DIAGNOSIS | VIRUS | RENAL-TRANSPLANTATION | PATHOLOGY | MEDIATED REJECTION | ORGAN TRANSPLANT RECIPIENTS | POLYOMAVIRUS BK NEPHROPATHY | NEPHRITIS | UROLOGY & NEPHROLOGY | ADENOVIRUS INFECTION | OF-THE-LITERATURE | Polyomavirus Infections - immunology | Adenovirus Infections, Human - therapy | Tumor Virus Infections - virology | Humans | Kidney - immunology | Tumor Virus Infections - diagnosis | Adenoviridae - pathogenicity | BK Virus - pathogenicity | Opportunistic Infections - therapy | Allografts | Tumor Virus Infections - immunology | Tumor Virus Infections - therapy | Opportunistic Infections - immunology | Adenoviridae - immunology | Immunosuppressive Agents - administration & dosage | Kidney - physiopathology | Opportunistic Infections - virology | Graft Rejection - prevention & control | Risk Factors | Adenovirus Infections, Human - immunology | Treatment Outcome | Adenovirus Infections, Human - diagnosis | BK Virus - immunology | Opportunistic Infections - diagnosis | Host-Pathogen Interactions | Polyomavirus Infections - diagnosis | Biopsy | Polyomavirus Infections - virology | Polyomavirus Infections - therapy | Immunosuppressive Agents - adverse effects | Graft Rejection - immunology | Immunocompromised Host | Graft Survival - drug effects | Kidney - virology | Adenovirus Infections, Human - virology | Kidney Transplantation - adverse effects | Medicine, Experimental | Medical research | Transplantation | Kidneys | Health aspects | Immunotherapy | Nephritis | Syngeneic grafts | Calcineurin | Calcineurin inhibitors | Clinical trials | Antimetabolites | Patients | Fever | Immunosuppressive agents | Graft rejection | Immunosuppression | Nephropathy | Remission | Drug discovery | Urination | Cystitis | Kidney transplantation
Journal Article
Transplantation, ISSN 0041-1337, 12/2012, Volume 94, Issue 11, pp. 1117 - 1123
Journal Article
Transplant Infectious Disease, ISSN 1398-2273, 08/2015, Volume 17, Issue 4, pp. 536 - 543
Background Up to 20% of renal transplant recipients (RTR) will develop human BK polyomavirus (BKPyV) viremia. BKPyV viremia is a pre‐requisite of... 
polyomavirus | polyomavirus‐associated nephropathy | BK virus | BKPyV viremia | renal transplantation | statins | Renal transplantation | Polyomavirus-associated nephropathy | Statins | Polyomavirus | INFECTIOUS DISEASES | polyomavirus-associated nephropathy | VIRUS-INFECTION | MANAGEMENT | IMMUNOLOGY | LOW-DOSE CIDOFOVIR | TRANSPLANTATION | HEART | REPLICATION | TUBULAR EPITHELIAL-CELLS | NEPHRITIS | UPDATE | KIDNEY | Polyomavirus Infections - etiology | Humans | Kidney Diseases - diagnosis | Middle Aged | Postoperative Complications - prevention & control | Tumor Virus Infections - diagnosis | Male | Incidence | Kidney Diseases - epidemiology | Adult | Female | Tumor Virus Infections - epidemiology | Pravastatin - therapeutic use | Viremia - diagnosis | Kidney Diseases - prevention & control | Polyomavirus Infections - prevention & control | Polyomavirus Infections - epidemiology | Treatment Outcome | Kidney Transplantation | Postoperative Complications - epidemiology | Tumor Virus Infections - prevention & control | Disease Progression | Postoperative Complications - diagnosis | BK Virus - isolation & purification | Polyomavirus Infections - diagnosis | Polyomavirus Infections - virology | Viremia - prevention & control | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Viremia - epidemiology | Kidney Diseases - virology | Aged | Kidney Diseases - etiology | Tumor Virus Infections - etiology | Viremia - etiology | Kidneys | Viremia | Immunotherapy | Organ transplant recipients | Transplantation | Kidney diseases | Pravastatin | Health aspects
Journal Article
Transplant Infectious Disease, ISSN 1398-2273, 04/2015, Volume 17, Issue 2, pp. 242 - 249
Background Recently, a platform of T‐cell replete haploidentical hematopoietic stem cell transplantation (haplo‐HSCT) using post‐transplant cyclophosphamide... 
antimicrobial prophylaxis | hematologic malignancies | infections | cyclophosphamide | T‐cell replete | haploidentical stem cell transplantation | Antimicrobial prophylaxis | Cyclophosphamide | Hematologic malignancies | Infections | T-cell replete | Haploidentical stem cell transplantation | SURVIVAL | INFECTIOUS DISEASES | DONOR | BONE-MARROW-TRANSPLANTATION | PHASE-II | IMMUNOLOGY | TRANSPLANTATION | ALLOGENEIC BLOOD | HIGH-RISK | POSTTRANSPLANTATION CYCLOPHOSPHAMIDE | LEUKEMIA | STEM-CELL TRANSPLANTATION | Haplotypes | Hematologic Neoplasms - therapy | Polyomavirus Infections - immunology | Mycoses - epidemiology | Cyclophosphamide - administration & dosage | Virus Diseases - epidemiology | Polyomavirus Infections - etiology | Prospective Studies | Bacterial Infections - etiology | Cytomegalovirus Infections - epidemiology | Humans | Middle Aged | Cystitis - immunology | Male | Cytomegalovirus Infections - immunology | Cyclophosphamide - adverse effects | Incidence | Young Adult | Bacterial Infections - immunology | Cytomegalovirus Infections - etiology | Adult | Female | Immunosuppressive Agents - administration & dosage | Cystitis - etiology | Virus Diseases - immunology | Polyomavirus Infections - epidemiology | Virus Diseases - etiology | Bacterial Infections - epidemiology | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Aged | Hematopoietic Stem Cell Transplantation - methods | Immunocompromised Host | Transplantation Conditioning | Mycoses - etiology | Mycoses - immunology | Cystitis - epidemiology | Cohort Studies | Virus diseases | Analysis | Stem cells | Mycoses | Dosage and administration | Transplantation | T cells | Health aspects | Hematopoietic stem cells
Journal Article